Kyle Faget Interview Highlighted in Digital Health Regulations Year in Review
December 6, 2022
MedTech Insight
Foley & Lardner LLP Partner Kyle Faget’s October interview with MedTech Insight is highlighted in their article, “Digital Health Regulations: A Year in Review,” which summarizes both the changes in digital health regulations in 2022 and what medical devices companies should look out for in the coming year.
Faget commented on the impact of the U.S. Food and Drug Administration’s (FDA) Clinical Decision Support Software (CDS) document, saying that some companies had to reevaluate whether their CDS products qualified as a device under the new guidance as the FDA took a broader approach to regulating that what was in its jurisdiction.
To read more about Faget’s earlier comments on this topic, click here.
Related News
June 2, 2026
In the News
Natasha Allen Authors Article on the Sectors Shaping America’s Next Economic Era
Foley & Lardner LLP partner Natasha Allen authored the Law.com article, “The Next 250: Which Sectors Will Define America’s Second Quarter-Millennium?” examining the industries poised to shape America’s next era and the legal and regulatory challenges accompanying their rapid growth.
June 2, 2026
In the News
Christopher McKenna Highlighted in Massachusetts Managing Partner Spotlight
Foley & Lardner LLP partner Christopher McKenna is featured in a Managing Partner Spotlight by Massachusetts Lawyers Weekly for his distinct leadership role and commitment to firm’s Boston office.
June 1, 2026
In the News
Gregory Husisian Analyzes U.S.–Taiwan Tariff Agreement and Trade Strategy Shifts
Foley & Lardner LLP partner Gregory Husisian is quoted in the Supply Chain Dive article, “US sets Taiwan tariffs at 15% on auto parts, wood, aircraft parts,” discussing the U.S.–Taiwan trade and investment agreement.